Cell MedX Corp. (OTCQB: CMXC) is a development-stage bio-tech company focused on the commercialization and development of microcurrent therapeutic devices that promote general wellness and alleviate complications associated with medical conditions including, but not limited to, diabetes, Parkinson’s disease, and high blood pressure.
Microcurrent therapy uses extremely low-level electrical currents to restore normal frequencies within cells, which can have a dramatic impact on health markers. In addition to increasing adenosine triphosphate (ATP) levels in cells, it enhances protein synthesis that can help with tissue repair. Increased blood flow and decreases in inflammation can lead to many possible benefits.
Download a free SECFilings Company Analysis on Cell MedX Corp. that covers:
Enter your e-mail below to receive the free analysis: